
Sign up to save your podcasts
Or


Recorded on 12/10/21
Cowen analyst Yaron Werber, M.D., speaks with Devang Bhuva, Senior Vice President, Corporate Development and Alliance Management at Gilead to get an inside look at the deal-making process from start to finish. In this episode of the Biotech Dealmakers Series, we discuss how deals get done, trends in oncology M&A, the framework that potential acquirers use to triage and identify potential targets, and what happens on both sides of the negotiating table.
For Disclosures, click here bit.ly/3cPHkNW
https://go.td.com/PodcastDisclosure
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By TD Securities, TD Cowen4.8
3636 ratings
Recorded on 12/10/21
Cowen analyst Yaron Werber, M.D., speaks with Devang Bhuva, Senior Vice President, Corporate Development and Alliance Management at Gilead to get an inside look at the deal-making process from start to finish. In this episode of the Biotech Dealmakers Series, we discuss how deals get done, trends in oncology M&A, the framework that potential acquirers use to triage and identify potential targets, and what happens on both sides of the negotiating table.
For Disclosures, click here bit.ly/3cPHkNW
https://go.td.com/PodcastDisclosure
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

3,067 Listeners

4,656 Listeners

1,932 Listeners

9,522 Listeners

940 Listeners

125 Listeners

322 Listeners

1,039 Listeners

290 Listeners

1,297 Listeners

9,927 Listeners

34 Listeners

517 Listeners

1,420 Listeners

44 Listeners